Skip to content

Bayer Faces Roundup Weedkiller Trial Featuring Ex-Monsanto CEO’s Testimony

  • Hugh Grant ran chemical maker for 15 years before Bayer buyout
  • Bayer battling 30,000 suits claiming Roundup causes cancer
Roundup brand weedkiller concentrate

Roundup brand weedkiller concentrate

Photographer: Daniel Acker/Bloomberg
Updated on

Bayer AG faces a trial over its Roundup weedkiller in which the ex-chief executive officer of its Monsanto unit will testify for the first time as to what he knew about the product’s cancer risks. 

Jurors in Kansas City, Missouri, are slated to hear opening arguments Tuesday in the trial of a lawsuit filed by a former Roundup user who blames the herbicide for causing him to develop non-Hodgkin lymphoma. Bayer, which acquired Roundup-maker Monsanto, has paid billions to settle tens of thousands of cases, but still faces about 30,000 suits over the product.